Siemens debuts tissue harmonic imaging
Siemens Ultrasound of Issaquah, WA, has become the latest ultrasound vendor to add tissue harmonic imaging capabilities to its product line. The firm's version, called Ensemble Tissue Harmonic Imaging, will be offered on its premium Sonoline Elegra
Siemens Ultrasound of Issaquah, WA, has become the latest ultrasound vendor to add tissue harmonic imaging capabilities to its product line. The firm's version, called Ensemble Tissue Harmonic Imaging, will be offered on its premium Sonoline Elegra ultrasound scanners.
The new release allows Elegra users to isolate harmonic signal data without the use of contrast agents, according to the firm. Ensemble supports high-frequency imaging and can provide demonstration of breast lesions and superficial images. The system also shows promise in scanning difficult-to-image patients.
Ensemble eliminates the impact of signal artifacts common during high-frequency scanning with its pulse-inversion technology, which isolates harmonic imaging signals, according to Siemens. Combining the harmonic imaging signals with fundamental signal data allows Elegra to yield improvements in tissue contrast and spatial resolution in nearly all radiological applications, the company believes.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
